Elder Bio Drugs Private Limited - Company Profile

It is a trading private limited company based in Indore, Madhya Pradesh, India, established in 2020.
2020 Indore, Madhya Pradesh, India Active
Last Updated:
Access Report
About Elder Bio Drugs Private Limited

Elder Bio Drugs Private Limited, a active private limited company, was established on 21 November 2020 in Indore, Madhya Pradesh, India. Engaging in wholesale within the trade sector, it holds CIN: U24110MP2020PTC053817. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Formerly known as Elder Lifesciences Private Limited. Its leadership includes Akhil Pahuja (Director), Aman Pahuja (Director). Its latest AGM occurred on 26 September 2025, with the balance sheet filed on 31 March 2025. It is based at 37-A Mangal Compound, Pipliya Kumar, Indore, Madhya Pradesh, 452010.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24110MP2020PTC053817

  • Registration Number

    053817

  • Incorporation Date

    21 November 2020

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Gwalior

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Profit Growth **** 239.73%
  • Ebitda **** 266.14%
  • Net Worth 313.74%
  • Total Assets -92.45%
Company report

Elder Bio Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Elder Bio Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Elder Bio Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Akhil Pahuja Director 21 Nov 2020 Current
Aman Pahuja Director 21 Nov 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Elder Bio Drugs.

Elder Bio Drugs Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 239.73% increase in profit. The company's net worth Soared by an impressive increase of 313.74%.

Elder Bio Drugs revenue growth over time
Elder Bio Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -92.45%
*******
*******
*******
*******
Profit or Loss
*******
 239.73%
*******
*******
*******
*******
Net Worth
*******
 313.74%
*******
*******
*******
*******
EBITDA
*******
 266.14%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Elder Bio Drugs?

Unlock access to Elder Bio Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Elder Bio Drugs?

Elder Bio Drugs has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Elder Bio Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elder Bio Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Elder Bio Drugs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Elder Bio Drugs Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Elder Bio Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior. was completed.

  • Director Appointment

    The activity Akhil Pahuja was appointed as a Director was appointed as a Director on 21 Nov 2020 & has been associated with this company since 5 years 4 months . was completed.

  • Director Appointment

    The activity Aman Pahuja was appointed as a Director was appointed as a Director on 21 Nov 2020 & has been associated with this company since 5 years 4 months . was completed.

  • Company Incorporation

    The activity Elder Bio Drugs Private Limited was registered on 21 Nov 2020 with Roc Gwalior & aged 5 years 4 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Elder Bio Drugs Private Limited?

The CIN of Elder Bio Drugs Private Limited is U24110MP2020PTC053817.

Where is Elder Bio Drugs Private Limited headquartered?

Elder Bio Drugs Private Limited is headquartered at 37-A Mangal Compound, Pipliya Kumar, Indore, Madhya Pradesh, 452010.

When was Elder Bio Drugs Private Limited incorporated?

Elder Bio Drugs Private Limited was incorporated on 21 November 2020.

Who are the current directors of Elder Bio Drugs Private Limited?

The current directors of Elder Bio Drugs Private Limited are

What is the primary industry of Elder Bio Drugs Private Limited?

The primary industry of Elder Bio Drugs Private Limited is Trade.

Is Elder Bio Drugs Private Limited a listed company?

Elder Bio Drugs Private Limited is unlisted.

What is the capital structure of Elder Bio Drugs Private Limited?

The authorized capital of Elder Bio Drugs Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available